Table 3 Antibiotic susceptibilities expressed as proportions of Gram-negative bacilli without (no MDR) and with MDR profile
From: Microbiological profile of patients treated for postoperative peritonitis: temporal trends 1999–2019
AMC | TZP | IMP | CTX | CAZ | GEN | AMK | CIP | LVX | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No MDR | MDR | No MDR | MDR | No MDR | MDR | No MDR | MDR | No MDR | MDR | No MDR | MDR | No MDR | MDR | No MDR | MDR | No MDR | MDR | |
Enterobacterales (n = 426) | 68 | 5 | 99 | 38 | 100 | 97 | 99 | 55 | 100 | 64 | 99 | 77 | 99 | 91 | 100 | 86 | 98 | 71 |
Escherichia coli (n = 200) | 82 | 7 | 100 | 60 | 100 | 98 | 100 | 85 | 100 | 88 | 100 | 81 | 99 | 99 | 100 | 96 | 97 | 73 |
Klebsiella spp. (n = 59) | 85 | 5 | 95 | 21 | 100 | 94 | 100 | 37 | 100 | 39 | 100 | 39 | 100 | 74 | 100 | 63 | 100 | 56 |
Enterobacter spp. (n = 78) | – | – | 100 | 5 | 100 | 97 | 93 | 5 | 100 | 10 | 96 | 79 | 100 | 79 | 100 | 65 | 97 | 70 |
Other Enterobacterales (n = 89) | 75 | 0 | 100 | 23 | 100 | 100 | 100 | 31 | 100 | 40 | 100 | 69 | 99 | 85 | 100 | 86 | 100 | 83 |
Non-fermenting GNB (n = 73) | – | – | 88 | 38 | 81 | 46 | – | – | 93 | 48 | 58 | 19 | 93 | 78 | 95 | 32 | – | – |
Pseudomonas aeruginosa (n = 65) | – | – | 93 | 42 | 90 | 50 | – | – | 100 | 53 | 60 | 23 | 98 | 86 | 95 | 33 | – | – |